Last reviewed · How we verify
NCT06353373: SmaVTE-BEST
Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies
trial testing Application of the modified DeVTEcare system in Venous Thromboembolism in 15,626 participants. Status unknown.
28 February 2025
Quick facts
| Lead sponsor | Navy General Hospital, Beijing |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 15,626 |
| Start date | 1 September 2024 |
| Primary completion | 28 February 2025 |
| Estimated completion | 28 February 2025 |
Drugs / interventions tested
- Application of the modified DeVTEcare system
Conditions studied
- Venous Thromboembolism — all drugs for Venous Thromboembolism →
- Clinical Decision Support Systems — all drugs for Clinical Decision Support Systems →
- Digital Health — all drugs for Digital Health →
Sponsor
Navy General Hospital, Beijing
Who can join
18 and older, any sex, with Venous Thromboembolism or Clinical Decision Support Systems. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Venous thromboembolism (VTE) is the third leading cause of cardiovascular disease deaths globally, and its incidence is increasing over the years. Hospital-acquired VTE accounts for approximately 75% of all deaths attributed to VTE. However, only half of patients with indications for VTE prophylaxis take preventive measures, and high rates of inappropriate VTE prophylaxis prescribing contribute to the gap between VTE prophylaxis and guidelines. To further minimize the gap between clinical practice and guidelines, a range of strategies have been employed across various fields of VTE prophylaxis. One of the most effective measures is the utilization of a Clinical Decision Support System (CDSS). Smart technology-based CDSS facilitates automated evaluation of VTE risk and detection, addressing issues at both the beginning and end of the in-hospital VTE prevention process. but there is still a lack of research on how to effectively implement evidence-based VTE prophylaxis in the middle of the process. In our hospital, routine use of DeVTEcare system (a CDSS for VTE risk assessment and integrated care) for in-hospital management of VTE has been launched since 2021. This study aims to investigate the effect of integrating bundled guideline-based VTE prevention strategies into the DeVTEcare system on in-hospital VTE prophylaxis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06353373
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Venous Thromboembolism
Currently open trials in the same condition.
- NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
- NCT06861088 — The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer · Phase 3 · recruiting
- NCT07140523 — A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA · Phase 2 · recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT06440694 — Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) · Phase 3 · recruiting
Other Navy General Hospital, Beijing trials
Trials by the same sponsor.
- NCT06382038 — Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism · NA · not yet recruiting
- NCT07184788 — G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma · Phase 2 · not yet recruiting
- NCT06938893 — Study on Cardiac Output Evaluation Based on Wearable Monitoring Data · not yet recruiting
- NCT06744894 — SIL as Maintenance Therapy in Multiple Myeloma · Phase 2 · not yet recruiting
- NCT06350344 — Smart Technology Facilitated Patient-centered Venous Thromboembolism Management · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06353373 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Navy General Hospital, Beijing
- Last refreshed: 9 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06353373.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing